MethodsX (Jan 2019)

Multiplexing fluorogenic esterase-based viability assay with luciferase assays

  • Kenji Ohgane,
  • Hiromasa Yoshioka,
  • Yuichi Hashimoto

Journal volume & issue
Vol. 6
pp. 2013 – 2020

Abstract

Read online

Luciferase-based reporter assays are one of the most common cell-based screening formats for drug discovery, and simultaneous evaluation of the cytotoxic effect of test compounds is of great value in reducing false-positives. Here we share a multiplex assay protocol that allows sequential measurement of cell viability (cell number) and luciferase activity of the same sample in a multi-well-plate format. The viability assay employs a fluorogenic esterase substrate, CytoRed. • This protocol allows sequential measurement of endogenous esterase activity (as a surrogate for cell number) and then luciferase activity in a single sample. • The protocol eliminates the need for parallel viability assay or protein assay using separate aliquots of the lysate. • This protocol is especially useful for assays with cells stably expressing a luciferase construct, for which co-transfection of another reporter gene is not a viable option. Method name: CytoRed-luciferase multiplex assay, Keywords: Multiplex assay, Luciferase, CytoRed, Esterase, Fluorogenic substrate, Viability